Señales en vivo de MIST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Stats
Volumen de hoy	85 271.00
Volumen promedio	330 017
Capitalización de mercado	89.82M
EPS	$0 ( 2024-04-03 )
Próxima fecha de ganancias	( $-0.260 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.220
ATR14	$0.00800 (0.47%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-07	Wills Robert James	Buy	30 000	Stock Option (right to buy)
2023-06-07	Tomsicek Michael John	Buy	30 000	Stock Option (right to buy)
2023-06-07	Pasternak Richard C	Buy	30 000	Stock Option (right to buy)
2023-06-07	Liebert Debra K.	Buy	30 000	Stock Option (right to buy)
2023-06-07	Giles Lisa M.	Buy	30 000	Stock Option (right to buy)

INSIDER POWER
2.08
Last 95 transactions
Buy: 18 033 611 \| Sell: 4 881 578

Volumen Correlación

Largo: -0.02 (neutral)

Corto: 0.20 (neutral)

Signal:(63.243) Neutral

Milestone Pharmaceuticals Correlación

10 Correlaciones Más Positivas
RMRM	0.881
GNUS	0.874
AADI	0.874
TANH	0.862
CIZN	0.834
MOTS	0.833
HYW	0.832
SEV	0.828
FCACU	0.819
SNCE	0.818

10 Correlaciones Más Negativas
LMRK	-0.927
QADA	-0.899
EYEG	-0.852
AGFS	-0.846
APEN	-0.84
MGYR	-0.837
STTK	-0.823
INBX	-0.811
BKCC	-0.806
MBINO	-0.804

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Milestone Pharmaceuticals Correlación - Moneda/Commodity

-0.01
( neutral )

0.20
( neutral )

0.00
( neutral )

-0.33
( neutral )

0.52
( weak )

-0.54
( weak negative )

Milestone Pharmaceuticals Finanzas

Annual	2023
Ingresos:	$1.00M
Beneficio Bruto:	$402 000 (40.20 %)
EPS:	$-1.390

FY	2023
Ingresos:	$1.00M
Beneficio Bruto:	$402 000 (40.20 %)
EPS:	$-1.390

FY	2022
Ingresos:	$5.00M
Beneficio Bruto:	$4.52M (90.40 %)
EPS:	$-1.350

FY	2021
Ingresos:	$15.00M
Beneficio Bruto:	$15.00M (100.00 %)
EPS:	$-1.460

Financial Reports:

No articles found.

Milestone Pharmaceuticals

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.

Actualizaciones en tiempo real para Milestone Pharmaceuticals [MIST]

Upcoming Earnings Alert